PGT Testing in IVF: Can Genetic Testing Improve Embryo Selection?

In vitro fertilization (IVF) has helped millions of couples achieve pregnancy, but not every embryo transfer leads to a live birth. One reason is that many embryos have chromosomal abnormalities that prevent implantation or cause miscarriage. Preimplantation Genetic Testing (PGT) offers a way to screen embryos before transfer, potentially improving success rates. This article explores PGT testing in IVF, its types, benefits, risks, and whether it truly improves embryo selection.

What Is PGT in IVF?

Preimplantation Genetic Testing (PGT) is a technique used alongside IVF to analyze embryos for genetic abnormalities before they are transferred to the uterus. Embryos are created in the lab, and on day 5 or 6 of development, a few cells are removed from the trophectoderm (the part that becomes the placenta). These cells are then sent for genetic analysis. Only embryos that appear genetically normal are selected for transfer.

PGT is not a treatment for infertility but a screening tool that helps identify which embryos have the best chance of leading to a healthy pregnancy. It can be particularly useful for couples with a known genetic disorder, recurrent pregnancy loss, or repeated IVF failure.

Types of PGT: PGT-A, PGT-M, and PGT-SR

There are three main types of PGT, each used for different purposes:

• PGT-A (Aneuploidy Screening): This screens embryos for an abnormal number of chromosomes (aneuploidy). For example, an embryo with an extra chromosome 21 would have Down syndrome. PGT-A can identify such embryos and help select euploid (normal) ones, potentially improving implantation rates and reducing miscarriage risk.
• PGT-M (Monogenic Disorders): This tests for specific inherited genetic conditions, such as cystic fibrosis, sickle cell disease, or Huntington’s disease. It is used when one or both parents carry a known mutation.
• PGT-SR (Structural Rearrangements): This screens for chromosomal structural abnormalities like translocations or inversions, which can lead to unbalanced embryos and recurrent miscarriages.

PGT-A is the most common type used in IVF to improve embryo selection. For couples seeking PGT testing in Hyderabad, many fertility clinics offer these advanced genetic screening options.

How Does PGT-A Work?

The process of PGT-A involves several steps:

1. IVF and Embryo Culture: Eggs are retrieved and fertilized with sperm to create embryos. These are cultured in the lab for 5–6 days until they reach the blastocyst stage.
2. Biopsy: A few cells (usually 5–10) are removed from the trophectoderm using a laser or micropipette. This is done by an experienced embryologist to minimize damage to the embryo.
3. Genetic Analysis: The biopsied cells are sent to a genetics lab for analysis. Next-generation sequencing (NGS) is commonly used to count chromosomes and detect aneuploidies.
4. Embryo Freezing: While waiting for results (usually 1–2 weeks), embryos are vitrified (frozen). This allows time for analysis without rushing the transfer.
5. Transfer: Only euploid embryos are thawed and transferred in a subsequent frozen embryo transfer (FET) cycle.

This approach is often combined with frozen embryo transfer, which has been shown to have comparable or better success rates than fresh transfer in some cases.

Can PGT Improve Embryo Selection?

The primary goal of PGT is to select the embryo with the highest potential for a successful pregnancy. By avoiding aneuploid embryos, PGT can:

• Increase implantation rates: Transferring euploid embryos leads to higher implantation rates per transfer.
• Reduce miscarriage rates: Most miscarriages are due to chromosomal abnormalities. PGT can reduce the risk of miscarriage by selecting normal embryos.
• Shorten time to pregnancy: By avoiding transfer of abnormal embryos that would fail or miscarry, patients may achieve a live birth sooner.
• Enable single embryo transfer (SET): With confidence in embryo quality, doctors can transfer one embryo at a time, reducing the risk of multiples.

However, PGT is not a guarantee of a live birth. Even euploid embryos can fail to implant due to other factors like uterine receptivity or maternal age. Moreover, PGT has a small error rate (approximately 1–2%) and can sometimes misdiagnose an embryo as abnormal when it is actually normal (false positive) or vice versa.

Who Should Consider PGT?

PGT is not recommended for everyone. The American Society for Reproductive Medicine (ASRM) suggests PGT-A may be beneficial for:

• Women aged 35 and older (higher risk of aneuploidy)
• Couples with recurrent pregnancy loss (two or more miscarriages)
• Couples with repeated IVF failure
• Carriers of a known genetic disorder or chromosomal translocation
• Severe male factor infertility (some studies show higher aneuploidy rates)

For younger women with good prognosis, PGT may not significantly improve live birth rates and adds extra cost and time. It is important to discuss with a fertility specialist whether PGT is right for your specific situation.

Risks and Limitations of PGT

While PGT is generally safe, there are some risks and limitations:

• Embryo damage: Although rare, the biopsy process can damage the embryo, potentially reducing its viability.
• Mosaicism: Some embryos have both normal and abnormal cells (mosaic). PGT may detect this, but interpretation is complex, and mosaic embryos can sometimes result in healthy births.
• Cost: PGT adds significant cost to an IVF cycle (typically $3,000–$5,000 in the US; costs vary in India).
• No embryo to transfer: In some cases, all embryos may be abnormal, leaving no embryo for transfer.
• False results: There is a small chance of misdiagnosis.

It is also important to note that PGT does not screen for all genetic disorders or birth defects. It only checks for chromosomal number or specific mutations tested.

PGT and the IVF Timeline

PGT lengthens the overall IVF process because embryos must be frozen while awaiting results. The typical IVF timeline with PGT includes an extra 1–2 weeks for genetic analysis and scheduling a frozen embryo transfer in a subsequent cycle.

Conclusion

PGT testing in IVF can improve embryo selection by identifying chromosomally normal embryos, leading to higher implantation rates and fewer miscarriages. However, it is not a magic bullet and is best suited for specific patient groups. Couples considering PGT should weigh the benefits against the added cost, time, and potential risks. Consulting with a fertility specialist and a genetic counselor can help determine if PGT is appropriate for your journey.

For more information on related topics, see our articles on blastocyst transfer and what to expect on embryo transfer day.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalized guidance.